我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

血管紧张素Ⅱ受体拮抗剂治疗充血性心力衰竭研究进展(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2002年第2期
页码:
167-169
栏目:
综述
出版日期:
2002-03-01

文章信息/Info

Title:
-
作者:
郭　明1;  王　亚2综述;  杨欣国3审校
1.武警云南总队医院, 云南昆明650111; 2.云南体委医院; 3.第四军医大学唐都医院心内科
Author(s):
-
关键词:
血管紧张素Ⅱ受体拮抗剂;  心力衰竭;  充血性
Keywords:
-
分类号:
R972;R541.61　
DOI:
-
文献标识码:
A
摘要:
血管紧张素Ⅱ受体拮抗剂是治疗充血性心力衰竭的新型药物, 由于其无血管紧张Ⅱ 逃逸, 且高效、低毒副作用, 有望成为治疗充血性心力衰竭的重要药物之一。
Abstract:
-

参考文献/References

[1] 侯应龙,臧益民.心力衰竭的分子生物学[J].心功能杂志,1998,10(2):96-97.

[2]胡厚祥,陈光辉,祝善俊.血管紧张素受体及其拮抗剂在心力衰竭中的作用机理[J].心功能杂志,1998,10(3):163-164.

[3]徐成斌.血管紧张素Ⅱ受体拮抗剂的基础特性与临床应用[J].心功能杂志,1999,11(1,2):36-38,102-105.

[4] Sander GE, Mckinnie JJ, Greenberg SS,et al. Angiotensin converting enzyme inhibitors and angiotensinⅡreceptor antagonist in the Treatment of heart failure caused by left ventricular systolic dysfunction[J].Prog Cardiovasc Dis, 1999,41(4):265-300.

[5] Inada Y, Ojima M, Kanagana K,et al. Pharmacologic properties of candesartan cilexetil-possible mechanisms of long-acting antihypertensive action[J].J Hum Hypertens,1999,12(supplI):S75-S80.

[6] Burnier M, Brunner HR, Comparativ antihypertensive effects of angiotensinⅡreceptor antagonist [J].J Am Soc Nephrol,1999,10(suppl 12):S278-S282.

[7] Meredith PA. Optimal closing characteristics of the angiotensin Ⅱreceptor antagonist telmisartan[J].Am J Cardiol,1999,84(2A):7K-12K.

[8] Leonardi A, Sironi G, Motta G. Receptors in Cardiovascular Disease: review and introduction[J].Pharm Acta Helv, 2000,74(2-3):157-161.

[9] Rocca HPB-L, Vaddadi G, Esler MD,et al. Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensinⅡantagonism[J].J Am Coll Cardiol, 1999,33(5):1163-1173.

[10]Kario K, Pickering T. Modification of hight blood pressure after myocardial infarction[J].Med Clin Nor Amer, 2000,84(1):1-21

[11]杨兵生,王声愿,蒋文平,等.氯沙坦对充血性心衰患者血循环中肿瘤坏死因子和白介素-6的干预[J].国外医学*心血管病分册, 2001,28(1):43-45.

[12]Mazayer VP, Fomina IG, Kazakow EN,et al. Valsartan in heart failure patients previously untreated with an ACE inhibitor[J].Int J Cardiol,1998,65(3):239-246.

[13]Krombach RS, Chair MJ, Hendrick JW,et al. Angiotensin converting enzyme inhibition, AT1receptor inhibition, and combination therapy with pacing induced heart failure effects on left ventricular perfomance and regional blood flow patterns[J].Cardiovasc Res,1998,38(3):631-645.

[14]Pitt B, Poole-Wilson PA, Segal R,et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial-the Losartan Heart Failure Survival Study ELITEⅡ[J].Lancet, 2000, 355 (9215):1582-1587.

[15]Burnier M.Angiotensin II Type 1 Receptor Blockers[J].Circulation, 2001, 103:904-912.

备注/Memo

备注/Memo:
收稿日期：2001-05-22.
更新日期/Last Update: 2002-03-01